LENZ Therapeutics, Inc. (NASDAQ:LENZ) Q4 2025 Earnings Call Transcript March 24, 2026
LENZ Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.16 EPS, expectations were $-0.904.
Operator: Good morning, ladies and gentlemen, and welcome to the LENZ Therapeutics Year-end 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this call is being recorded. At this time, I would like to turn the call over to Dan Chevallard, Chief Financial Officer....
